United Kingdom · Question · Written question
UIN 38493
Givinostat
Introduced
14 March 2025
Last action
26 March 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
26 March 2025
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of delays in accessing givinostat through the Early Access Programme on boys and young men living with Duchenne muscular dystrophy in the UK.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
14 March 2025
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of delays in accessing givinostat through the Early Access Programme on boys and young men living with Duchenne muscular dystrophy in the UK.
Source: Commons
26 March 2025
Answer
The Department understands the impact that Duchenne muscular dystrophy has on those living with it and their families, and the urgent need for new treatment options. The National Institute for Health and Care Excellence (NICE) recently published guidance ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-03-14/38493
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1785025
- uk · wq-1785025 · source updated 26 March 2025